TrialJournal for immunotherapy of cancer2026

Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trials.

BaoQing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.